Novo Nordisk A/S: CagriSema 2.4 mg
Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction in the highest range of efficacy observed with existing weight loss interventions1When adhering to treatment,…